期刊文献+

锯叶棕果实提取物软胶囊治疗良性前列腺增生的有效性和安全性分析 被引量:8

Efficacy and safety of Saw Palmetto Extract Capsules in the treatment of benign prostatic hyperplasia
原文传递
导出
摘要 目的:探讨锯叶棕果实提取物软胶囊治疗良性前列腺增生(BPH)的有效性和安全性。方法:采用多中心、开放性临床研究,对临床和实验室确诊的165例BPH患者给予锯叶棕果实提取物软胶囊口服1粒/次(160 mg),1次/d,6周后及12周试验结束时比较患者治疗前后的疗效。主要疗效指标:IPSS评分、前列腺体积、残余尿量;次要疗效指标:尿流率、生活质量评分(QOL)。结果:治疗6周后,患者的国际前列腺症状评分(IPSS)和QOL较前有所改善,治疗12周后,患者的IPSS评分、QOL评分、尿流率、残余尿较治疗前均有明显改善。研究过程中有1例不良事件发生。结论:锯叶棕果实提取物软胶囊治疗BPH是有效和安全的。 Objective: To assess the efficacy and safety of Saw Palmetto Extract Capsules in the treatment of benign prostatic hyperplasia( BPH). Methods: We conducted a multi-centered open clinical study on 165 BPH patients treated with Saw Palmetto Extract Capsules at a dose of 160 mg qd for 12 weeks. At the baseline and after 6 and 12 weeks of medication,we compared the International Prostate Symptom Scores( IPSS),prostate volume,postvoid residual urine volume,urinary flow rate,quality of life scores( QOL),and adverse events between the two groups of patients. Results: Compared with the baseline,both IPSS and QOL were improved after 6 weeks of medication,and at 12 weeks,significant improvement was found in IPSS,QOL,urinary flow rate,and postvoid residual urine. Mild stomachache occurred in 1 case,which necessitated no treatment. Conclusion: Saw Palmetto Extract Capsules were safe and effective for the treatment of BPH.
出处 《中华男科学杂志》 CAS CSCD 北大核心 2015年第12期1098-1101,共4页 National Journal of Andrology
关键词 锯叶棕果实提取物 良性前列腺增生 有效性 安全性 saw palmetto extract benign prostatic hyperplasia efficacy safety
  • 相关文献

参考文献4

二级参考文献42

  • 1孙颖浩.α1受体阻滞剂治疗良性前列腺增生研究进展[J].中华男科学杂志,2004,10(7):483-485. 被引量:24
  • 2熊鹰,叶璐,任宇,李懿,宋豪,李宁宁,初铮铮,李幼平.特拉唑嗪、非那司提和坦素罗辛治疗良性前列腺增生症的有效性评价[J].中国循证医学杂志,2005,5(6):448-454. 被引量:10
  • 3吴阶平.吴阶平泌尿外科学[M].济南:山东科学技术出版社,2004.589-591.
  • 4Nasu K,Moriyama N,Kawabe K,et al.Quantification and distribution of alpha1-adrenoceptor subtype mRNAs in human prostate:comparison of benign hypertrophied tissue and non-hypertrophied tissue[J].Br J Pharmacol,1996,119(6):797-803.
  • 5Muramatsu I,Taniguchi T,Okada K.Tamsulosin:alpha1 adrenoceptor subtype 2 selectivity and comparison with terazosin[J].Jpn J Pharmacol,1998,78(3):331-335.
  • 6Taniguchi N,Ukai Y,Tanaka T,et al.Identification of alpha1-adrenoceptor subtypes in the human prostatic urethra[J].Naunyn Schmiedebergs Arch Pharmacol,1997,355 (3):412-416.
  • 7Yashiyama M,De Groat WC.Role of spinal alpha-adrenoceptor subtypes in the bladder reflex in anesthetized rats[J].Am J Physiol Regul Integr Comp Physiol,2001,280 (5):R1414-1419.
  • 8Marinese D,Patel R,Walden PD,et al.Mechanistic investigation of the adrenergic induction of ventral prostate hyperplasia in mice[J].Prostate,2003,54(3):230-237.
  • 9Golomb E,Rosenzweig N,Eilam R,et al.Spontaneous hyperplasia of the ventral lob of the prostate in aging genetically hypertensive rats[J].J Androl,2000,21(1):58-64.
  • 10AUA Practice Guidelines Committee.AUA guideline on management of benign prostatic hyperplasia (2003).Chapter:diagnosis and treatment recommendations[J].J Urol,2003,170(2pt1):530-547.

共引文献148

同被引文献66

引证文献8

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部